FDA updates labeling for SYNALGOS-DC
Labeling changes approved for SUN PHARM INDUSTRIES. Active ingredient: ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE. Decision date: 12/22/2025
Labeling changes approved for SUN PHARM INDUSTRIES. Active ingredient: ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE. Decision date: 12/22/2025
There are no comments here yet...